Abstract
Acute pancreatitis is a common inflammatory disorder of the pancreas resulting in considerable morbidity and a mortality rate of approximately 5 %. Although there are no pharmacologic treatments known to improve important outcomes, aggressive intravenous fluid resuscitation is generally recommended in all patients. Recent human investigations have been performed in an attempt to answer several important questions that have not been answered, particularly in reference to the optimal resuscitative fluid, the role for colloid solutions, the ideal target clinical marker for fluid resuscitation, as well as the ideal time points for fluid administration. This review begins with a discussion related to the microcirculation of the pancreas and the pathophysiologic alterations caused by acute pancreatitis. Previous animal experiments will be described, as will the current status of recent and planned human studies specifically addressing fluid resuscitation. Finally, current recommendations and goals for further investigation will be highlighted. It is our hope that this review will stimulate interest in this previously overlooked subject and lead to further carefully designed prospective human clinical trials in the future.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
National Center for Health Statistics. National hospital discharge summary: annual summary 1998; series report 13:203.
DeFrances CJ, Hall MJ, Podgornik MN. National Hospital Discharge Survey: advance data from vital and health statistics. Hyattsville, MD: National Center for Health Statistics; 2005. p. 359.
Mann DV, Hershman MJ, Hittinger R, Glazer G. Multicentre audit of death from acute pancreatitis. Br J Surg. 1984;81:890–3.
Neoptolemos JP, Raraty M, Finch M, Sutton R. Acute pancreatitis: the substantial human and financial costs. Gut. 1998;42:886–91.
Blum T, Lowenfels AB, Lankisch PG. Fatal outcome in acute pancreatitis: its occurrence and early prediction. Pancreatology. 2001;1:237–41.
Appelros S, Lindgren S, Borgstrom A. Short and long term outcome of severe acute pancreatitis. Eur J Surg. 2001;167:281–6.
Vege SS, Baron TH. Management of pancreatic necrosis in severe acute pancreatitis. Clin Gastroenterol Hepatol. 2005;3:192–6.
Morimoto T, Noguchi Y, Sakai T, Shimbo T, Fukui T. Acute pancreatitis and the role of histamine-2 receptor antagonists: a meta-analysis of randomized controlled trials of cimetidine. Eur J Gastroenterol Hepatol. 2002;14:679–86.
Cameron J, Mehigan D, Zuidema GD. Evaluation of atropine in acute pancreatitis. Surg Gynecol Obstet. 1979;148:206–8.
Testoni PA, Bagnolo F, Andriulli A, Bernasconi G, Crotta S, Lella F, et al. Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial. Aliment Pharmacol Ther. 2001;15:965–72.
Uhl W, Buchler MW, Malfertheiner P, Beger HG, Adler G, Gaus W. A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis. Gut. 1999;45:97–104.
Hirata K. Essential therapeutic strategies for acute pancreatitis—guidelines for initial treatment and their significance. Nippon Rinsho. 2004;62:2049–56.
Andriulli A, Leandro G, Clemente R, Festa V, Caruso N, Annese V, et al. Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis. Aliment Pharmacol Ther. 1998;12:237–45.
Heinrich S, Schafer M, Rousson V, Clavien PA. Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg. 2006;243:154–68.
Imrie CW, McKay CJ. The possible role of platelet-activating factor antagonist therapy in the management of severe acute pancreatitis. Baillieres Best Pract Res Clin Gastroenterol. 1999;13:357–64.
Elmunzer BJ, Scheiman JM, Lehman GA, Chak A, Mosler P, Higgins PD, et al. A randomized trial of rectal indomethacin to prevent post-ERCP Pancreatitis. N Engl J Med. 2012;366:1414–22.
Folsch UR, Nitsche R, Ludtke R, Hilgers RA, Creutzfeldt W. Early ERCP and papillotomy compared with conservative treatment for acute biliary pancreatitis. N Engl J Med. 1997;336:237–42.
Tenner S. Initial management of acute pancreatitis: critical issues during the first 72 hours. Am J Gastroenterol. 2004;99:2489–94.
Bockman D. An introduction to surgical anatomy and neuroanatomy. In: Beger HC et al., editors. The Pancreas, vol. 1. Oxford: Blackwell Science Ltd; 1998. p. 11–8.
Cuthbertson CM, Christophi C. Disturbances of the microcirculation in acute pancreatitis. Br J Surg. 2006;93:518–30.
Mikami Y, Takeda K, Murakami T, et al. Vascular anatomy of the pancreas. In: Pour P, editor. Toxicology of the pancreas. Boca Raton, FL: Taylor & Francis; 2006. p. 75–89.
Sweiry JH, Mann GE. Pancreatic microvascular permeability in caerulein-induced acute pancreatitis. Am J Physiol. 1991;261:G685–92.
Bonner-Weir S. The microvasculature of the pancreas, with emphasis on that of the iselt of Langerhans. In: Go VLW et al., editors. The pancreas: biology, pathobiology and disease. 2nd ed. New York: Raven; 1993. p. 759–68.
Plusczyk T, Rathgeb D, Westermann S, Feifel G. Effects of somatostatin (SMS) on pancreatic microcirculation. Dig Dis Sci. 1997;42:2254–63.
Knoefel WT, Kollias N, Warshaw A, Waldner H, Nishioka NS, Rattner DW. Pancreatic microcirculatory changes in experimental pancreatitis of graded severity in rat. Surgery. 1994;116:904–13.
Strate T, Mann O, Kleinhans H, Rusani S, Schneider C, Yekebas E, et al. Microcirculatory function and tissue damage is improved after therapeutic injection of bovine hemoglobin in severe acute rodent pancreatitis. Pancreas. 2005;30:254–9.
Bassi D, Kollias N, Fernandez-del Castillo C, Foitzik T, Warshaw AL, Rattner DW. Impairment of pancreatic microcirculation correlates with the severity of acute experimental pancreatitis. J Am Coll Surg. 1994;179:257–63.
Borodin YI, Vasilyeva MB, Larionov PM, Astashov VV, Yankaite EV. Hemolymphomicrocirculatory bed of the pancreas during acute experimental pancreatitis. Bull Exp Biol Med. 2006;141:491–2.
Pandol SJ, Saluja AK, Imrie CW, Banks PA. Acute pancreatitis: bench to the bedside. Gastroenterology. 2007;132:1127–51.
Foitzik T, Hotz HG, Eibl G, Hotz B, Kirchengast M, Buhr HJ. Therapy for microcirculatory disorders in severe acute pancreatitis: effectiveness of platelet-activating factor receptor blockade vs. endothelin receptor blockade. J Gastrointest Surg. 1999;3:244–51.
Foitzik T, Eibl G, Buhr HJ. Therapy for microcirculatory disorders in severe acute pancreatitis: comparison of delayed therapy with ICAM-1 antibodies and a specific endothelin A receptor antagonist. J Gastrointest Surg. 2000;4:240–6.
Freitag M, Standl TG, Kleinhans H, Gottschalk A, Mann O, Rempf C, et al. Improvement of impaired microcirculation and tissue oxygenation by hemodilution with hydroxyethyl starch plus cell-free hemoglobin in acute porcine pancreatitis. Pancreatology. 2006;6:232–9.
Kerner T, Vollmar B, Menger MD, Waldner H, Messmer K. Determinants of pancreatic microcirculation in acute pancreatitis in rats. J Surg Res. 1996;62:165–71.
Takada Y, Appert HE, Howard JM. Vascular permeability induced by pancreatic exudate formed during acute pancreatitis in dogs. Surg Gynecol Obstet. 1976;143:779–83.
Bockman DE. Microvasculature of the pancreas: relation to pancreatitis. Int J Pancreatol. 1992;12:11–21.
Vollmar B, Menger MD. Microcirculatory dysfunction in acute pancreatitis: a new concept of pathogenesis involving vasomotion-associated arteriolar constriction and dilation. Pancreatology. 2003;3:181–90.
Sanfey H, Cameron JL. Increased capillary permeability: an early lesion in acute pancreatitis. Surgery. 1984;96:485–91.
Klar E, Messmer K, Warshaw AL, Herfarth C. Pancreatic ischaemia in experimental acute pancreatitis: mechanism, significance and therapy. Br J Surg. 1990;77:1205–10.
Zhou ZG, Chen YD. Influencing factors of pancreatic microcirculatory impairment in acute pancreatitis. World J Gastroenterol. 2002;8:2103–11.
Klar E, Schratt W, Foitzik T, Buhr H, Herfarth C, Messmer K. Impact of microcirculatory flow pattern changes on the development of acute edematous and necrotizing pancreatitis in rabbit pancreas. Dig Dis Sci. 1994;39:2639–44.
Klar E, Endrich B, Messmer K. Microcirculation of the pancreas. A quantitative study of physiology and changes in pancreatitis. Int J Microcirc Clin Exp. 1990;9:85–101.
Kusterer K, Poschmann T, Friedemann A, Enghofer M, Zendler S, Usadel KH. Arterial constriction, ischemia-reperfusion, and leukocyte adherence in acute pancreatitis. Am J Physiol. 1993;265:G165–71.
Schroder T, Kivisaari L, Standertskjold-Nordenstam CG, Somer K, Lehtola A, Puolakkainen P, et al. Pancreatic blood flow and contrast enhancement in computed tomography during experimental pancreatitis. Eur Surg Res. 1985;17:286–91.
Takeda K. Role of increase in permeability and circulatory failure in the development of organ dysfunction in severe acute pancreatitis. Nippon Rinsho. 2004;62:1999–2004.
Ranson JH, Lackner H, Berman IR, Schinella R. The relationship of coagulation factors to clinical complications of acute pancreatitis. Surgery. 1977;81:502–11.
Salomone T, Tosi P, Palareti G, Tomassetti P, Migliori M, Guariento A, et al. Coagulative disorders in human acute pancreatitis: role for the D-dimer. Pancreas. 2003;26:111–6.
Toyama MT, Lewis MP, Kusske AM, Reber PU, Ashley SW, Reber HA. Ischaemia-reperfusion mechanisms in acute pancreatitis. Scand J Gastroenterol Suppl. 1996;219:20–3.
Bhatnagar A, Wig JD, Majumdar S. Expression of activation, adhesion molecules and intracellular cytokines in acute pancreatitis. Immunol Lett. 2001;77:133–41.
Rau B, Poch B, Gansauge F, Bauer A, Nüssler AK, Nevalainen T, et al. Pathophysiologic role of oxygen free radicals in acute pancreatitis: initiating event or mediator of tissue damage? Ann Surg. 2000;231:352–60.
Schoenberg MH, Buchler MW, Younes M, Kirchmayr R, Brückner UB, Beger HG. Effect of antioxidant treatment in rats with acute hemorrhagic pancreatitis. Dig Dis Sci. 1994;39:1034–40.
Takeda K, Mikami Y, Fukuyama S, Egawa S, Sunamura M, Ishibashi T, et al. Pancreatic ischemia associated with vasospasm in the early phase of human acute necrotizing pancreatitis. Pancreas. 2005;30:40–9.
Baron TH, Thaggard WG, Morgan DE, Stanley RJ. Endoscopic therapy for organized pancreatic necrosis. Gastroenterology. 1996;111:755–64.
Dimagno MJ, Williams JA, Hao Y, Ernst SA, Owyang C. Endothelial nitric oxide synthase is protective in initiation of caerulein-induced acute pancreatitis in mice. Am J Physiol Gastrointest Liver Physiol. 2004;287:G80–7.
Eibl G, Hotz HG, Faulhaber J, Kirchengast M, Buhr HJ, Foitzik T. Effect of endothelin and endothelin receptor bloackade on capillary permeability in experimental pancreatitis. Gut. 2000;46:390–4.
Hackert T, Werner J, Gebhard MM, Klar E. Effects of heparin in experimental models of acute pancreatitis and post-ERCP pancreatitis. Surgery. 2004; 135:131–8.
Zyromski N, Murr MM. Evolving concepts in the pathophysiology of acute pancreatitis. Surgery. 2003;133:235–7.
Pezzilli R, Fantini L, Morselli-Labate AM. New approaches for the treatment of acute pancreatitis. Pancreas. 2006;7:79–91.
Hughes CB, Grewal HP, Gaber LW, Kotb M, El-din AB, Mann L. Anti- TNF-a therapy improves survival and ameliorates the pathophysiology sequelae in acute pancreatitis in the rat. Am J Surg. 1996;171:274–80.
Hughes CB, Gaber LW, Mohey el-Din AB, Grewal HP, Kotb M, Mann L, et al. Inhibition of TNF alpha improves survival in an experimental model of acute pancreatitis. Am Surg. 1996;62:8–13.
Norman J, Franz M, Messina J, Riker A, Fabri PJ, Rosemurgy AS, et al. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery. 1995;117:648–55.
Li W, Yan X, Wang H, Zhang Z, Yu W, Ji D, et al. Effects of continuous high-volume hemofiltration on experimental severe acute pancreatitis in pigs. Pancreas. 2007;34:112–9.
Wang HLW, Zhou W, Li N, Li JS. Clinical effects of continuous high volume hemofiltration on severe acute pancreatitis complicated with multiple organ dysfunction syndrome. World J Gastroenterol. 2003;9:2096–9.
Banks PA, Freeman ML. Practice guidelines in acute pancreatitis. Am J Gastroenterol. 2006;101:2379–400.
Baron TH, Morgan DE. Acute necrotizing pancreatitis. N Engl J Med. 1999;340:1412–7.
Clancy TE, Ashley SW. Current management of necrotizing pancreatitis. Adv Surg. 2002;36: 103–21.
Purcaru F, Ghelase F, Gugila I, Curcă T, Nemeş R, Georgescu I, et al. Resuscitation principles in severe acute pancreatitis complicated by multiple organ dysfunctions. Chirurgia. 1997;92:309–23.
Horton JW, Burnweit CA. Hemodynamic function in acute pancreatitis. Surgery. 1988;103:538–46.
Juvonen PO, Tenhunen JJ, Heino AA, Merasto M, Paajanen HE, Alhava EM, et al. Splanchnic tissue perfusion in acute experimental pancreatitis. Scand J Gastroenterol. 1999;34:308–14.
Niederau C, Crass RA, Silver G, Ferrell LD, Grendell JH. Therapeutic regimens in acute experimental hemorrhagic pancreatitis. Effects of hydration, oxygenation, peritoneal lavage, and a potent protease inhibitor. Gastroenterology. 1988;95:1648–57.
Knol JA, Inman MG, Strodel WE, Eckhauser FE. Pancreatic response to crystalloid resuscitation in experimental pancreatitis. J Surg Res. 1987;43:387–92.
Martin DT, Steinberg SM, Kopolovic R, Carey LC, Cloutier CT. Crystalloid versus colloid resuscitation in experimental hemorrhagic pancreatitis. Surg Gynecol Obstet. 1984;159:445–9.
Shields CJ, Winter DC, Sookhai S, Ryan L, Kirwan WO, Redmond HP. Hypertonic saline attenuates end-organ damage in an experimental model of acute pancreatitis. Br J Surg. 2000;87: 1336–40.
Shields CJ, Sookhai S, Winter DC, Dowdall JF, Kingston G, Parfrey N, et al. Attenuation of pancreatitis-induced pulmonary injury by aerosolized hypertonic saline. Surg Infect. 2001;2:215–23.
Schmidt J, Fernandez-del Castillo C, Rattner DW, Lewandrowski KB, Messmer K, Warshaw AL. Hyperoncotic ultrahigh molecular weight dextran solutions reduce trypsinogen activation, prevent acinar necrosis, and lower mortality in acute pancreatitis. Am J Surg. 1993;165:40–4.
Schmidt J, Huch K, Mithofer K, Hotz HG, Sinn HP, Buhr HJ, et al. Benefits of various dextrans after delayed therapy in necrotizing pancreatitis of the rat. Intensive Care Med. 1996;22:1207–13.
Donaldson LA, Schenk WJ. Experimental acute pancreatitis: the changes in pancreatic oxygen consumption and the effect of Dextran 40. Ann Surg. 1979;190:728–31.
Klar E, Foitzik T, Buhr H, Messmer K, Herfarth C. Isovolemic hemodilution with dextran 60 as treatment of pancreatic ischemia in acute pancreatitis. Clinical practicability of an experimental concept. Ann Surg. 1993;217:369–74.
Klar E, Herfarth C, Messmer K. Therapeutic effect of isovolemic hemodilution with dextran 60 on impairment of pancreatic microcirculation in acute biliary pancreatitis. Ann Surg. 1990;211: 346–53.
Knol JA, Edgcomb LP, Inman MG, Eckhauser FE. Low molecular weight dextran in experimental pancreatitis: effects on pancreatic microcirculation. J Surg Res. 1983;35:73–82.
Horton JW, Dunn CW, Burnweit CA, Walker PB. Hypertonic saline-dextran resuscitation of acute canine bile-induced pancreatitis. Am J Surg. 1989;158:48–56.
Strate T, Mann O, Kleinhans H, Schneider C, Knoefel WT, Yekebas E, et al. Systemic intravenous infusion of bovine hemoglobin significantly reduces microcirculatory dysfunction in experimentally induced pancreatitis in the rat. Ann Surg. 2003;238:765–71.
Leese T, West KP, Mortin DB. Fresh forzen plasma in acute pancreatitis: an experimental study. Int J Pancreatol. 1988;3:437–47.
Baillargeon JD, Orav J, Ramagopal V, Tenner SM, Banks PA. Hemoconcentration as an early risk factor for necrotizing pancreatitis. Am J Gastroenterol. 1998;93:2130–4.
Gardner TB, Olenec CA, Chertoff JD, Mackenzie TA, Robertson DJ. Hemoconcentration and pancreatic necrosis: further defining the relationship. Pancreas. 2006;33:169–73.
Lankisch PG, Mahlke R, Blum T, Bruns A, Bruns D, Maisonneuve P, et al. Hemoconcentration: an early marker of severe and/or necrotizing pancreatitis? A critical appraisal. Am J Gastroenterol. 2001;96:2081–5.
Gan SI, Romagnuolo J. Admission hematocrit: a simple, useful and early predictor of severe pancreatitis. Dig Dis Sci. 2004;49:1946–52.
Brown A, Orav J, Banks PA. Hemoconcentration is an early marker for organ failure and necrotizing pancreatitis. Pancreas. 2000;20:367–72.
Brown A, Baillargeon JD, Hughes MD, Banks PA. Can fluid resuscitation prevent pancreatic necrosis in severe acute pancreatitis? Pancreatology. 2002;2:104–7.
Bardarian A, Shah T, Li JJ, et al. Initial intravenous hydration in acute pancreatitis contributing to unchanged morality 1994 and 2004. Am J Gastroenterol. 2005;100:S714.
Eckerwall G, Olin H, Andersson B, Andersson R. Fluid resuscitation and nutritional support during severe acute pancreatitis in the past: what have we learned and how can we do better? Clin Nutr. 2006;25:497–504.
Mao EQ, Tang YQ, Li L, Qin S, Wu J, Liu W, et al. Strategy of controlling fluid resuscitation for severe acute pancreatitis in acute phase. Zhonghua Wai Ke Za Zhi. 2007;45:1331–4.
de Madaria E, Soler-Sala G, Sánchez-Payá J, Lopez-Font I, Martínez J, Gómez-Escolar L, et al. Influence of fluid therapy on the prognosis of acute pancreatitis: a prospective cohort study. Am J Gastroenterol. 2011;106(10):1843–50.
Wang ZF, Liu C, Lu Y, Dong R, Xu J, Yu L, et al. Dexamethasone and dextran 40 treatment of 32 patients with severe acute pancreatitis. World J Gastroenterol. 2004;10(9):1333–6.
Wu BU, Hwang JQ, Gardner TB, Repas K, Delee R, Yu S, et al. Lactated Ringer’s solution reduces systemic inflammation compared with saline in patients with acute pancreatitis. Clin Gastroenterol Hepatol. 2011;9(8):710–7.
Warndorf MG, Kurtzman JT, Bartel MJ, Cox M, Mackenzie T, Robinson S, et al. Early fluid resuscitation reduces morbidity among patients with acute pancreatitis. Clin Gastroenterol Hepatol. 2011; 9(8):705–9.
Mao EQ, Fei J, Peng YB, Huang J, Tang YQ, Zhang SD. Rapid hemodilution is associated with increased sepsis and mortality among patients with severe acute pancreatitis. Chin Med J. 2010;123(13): 1639–44.
de-Madaria E, Banks PA, Moya-Hoyo N, Wu BU, Rey-Riveiro M, Acevedo-Piedra NG, et al. Early factors associated with fluid sequestration and outcomes of patients with acute pancreatitis. Clin Gastroenterol Hepatol 2013 Oct 29 [epub ahead of print]
Tenner S, Baillie J, DeWitt J, Vege SS, American College of Gastroenterology. American college of gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013;108:1400–15.
Talukdar R, Vege S. Early management of severe acute pancreatitis. Curr Gastroenterol Rep. 2011; 13(2):123–30.
Forsmark CE, Baillie J. AGA institute technical review on acute pancreatitis. Gastroenterology. 1997;132:2022–44.
Whitcomb DC. Clinical practice: acute pancreatitis. N Engl J Med. 2006;354:2142–50.
Vege SS, Chari ST, Clain JE. Severe acute pancreatitis. JAMA. 2004;291:2865–8.
Wall I, Badalov N, Baradarian R, Iswara K, Li JJ, Tenner S. Decreased mortality in acute pancreatitis related to early aggressive hydration. Pancreas. 2011;30:547–50.
Gardner TB, Vege SS, Chari ST, Petersen BT, Topazian MD, Clain JE, et al. Faster rate of initial fluid resuscitation in severe acute pancreatitis diminishes in-hospital mortality. Pancreatology. 2009;9:770–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sampath, K., Gardner, T.B. (2015). Fluid Resuscitation in Acute Pancreatitis. In: Forsmark, C., Gardner, T. (eds) Prediction and Management of Severe Acute Pancreatitis. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0971-1_8
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0971-1_8
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-0970-4
Online ISBN: 978-1-4939-0971-1
eBook Packages: MedicineMedicine (R0)